1887

Abstract

Multi-resistant have recently occured in several nosocomial outbreaks of septicaemia. An animal model resembling the pathophysiology of these infections in man would be very useful. A new model of endogenous septicaemia caused by and strains in mice has been established. The mortality rate of conventional ddY mice given cyclophosphamide (CY) or fluorouracil (5-FU), each 200 mg/kg intraperitoneally, every other day was 70 and 100%, respectively. septicaemia was observed in all dead mice treated with CY, whereas Enterobacteriaceae, including , were isolated from 90% of mice given 5-FU. Specific-pathogen-free mice, decontaminated with ampicillin and ceftazidime, were given multi-resistant CF504, CF514 or CF604, or CF614 carrying CAZ-1/TEM-5 plasmid by oral inoculation. Subsequent dosing with 5-FU induced lethal septicaemia caused by the inoculated strains in most of these mice, whereas CY did not regularly induce septicaemia. This model with 5-FU is considered to resemble closely the situation observed in man and to be beneficial for investigating pathophysiology and therapeutic strategies.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/00222615-44-3-211
1996-03-01
2024-03-28
Loading full text...

Full text loading...

/deliver/fulltext/jmm/44/3/medmicro-44-3-211.html?itemId=/content/journal/jmm/10.1099/00222615-44-3-211&mimeType=html&fmt=ahah

References

  1. Brun-Buisson C., Legrand P., Philippon A., Montravers F., Ansquer M., Duval J. Transferable enzymatic resistance to third-generation cephalosporins during nosocomial outbreak of multiresistant Klebsiella pneumoniae . Lancet 1987; 2:302–306
    [Google Scholar]
  2. De Champs C., Sauvant M. P., Chanal C. Prospective survey of colonization and infection caused by expanded-spectrum-beta-lactamase-producing members of the family Enterobacteriaceae in an intensive care unit. J Clin Microbiol 1989; 27:2887–2890
    [Google Scholar]
  3. Sirot J., Chanal C., Petit A., Sirot D., Labia R., Getbaud G. Klebsiella pneumoniae and other enterobacteriaceae producing novel plasmid-mediated β-lactamases markedly active against third-generation cephalosporins: epidemiologic studies. Rev Infect Dis 1988; 10:850–859
    [Google Scholar]
  4. Petit A., Sirot D. L., Chanal C. M. Novel plasmid-mediated beta-lactamase in clinical isolates of Klebsiella pneumoniae more resistant to ceftazidime than to other broad-spectrum cephalosporins. Antimicrob Agents Chemother 1988; 32:626–630
    [Google Scholar]
  5. Sirot D., Sirot J., Labia R. Transferable resistance to third-generation cephalosporins in clinical isolates of Klebsiella pneumoniae: identification of CTX-1, a novel beta-lactamase. J Antimicrob Chemother 1987; 20:323–334
    [Google Scholar]
  6. Markowitz S. M., Veazey J. M., Macrina F. L., Mayhall C. G., Lamb V. A. Sequential outbreaks of infection due to Klebsiella pneumoniae in a neonatal intensive care unit: implication of a conjugative R plasmid. J Infect Dis 1980; 142:106–112
    [Google Scholar]
  7. Hirakata Y., Tomono K., Tateda K. Role of bacterial association with Kupffer cells in occurrence of endogenous systemic bacteremia. Infect Immun 1991; 59:289–294
    [Google Scholar]
  8. Hirakata Y., Kaku M., Tomono K. Efficacy of erythromycin lactobionate for treating Pseudomonas aeruginosa bacteremia in mice. Antimicrob Agents Chemother 1992; 36:1198–1203
    [Google Scholar]
  9. Darfeuille-Michaud A., Jallat C., Aubel D. R-plasmid-encoded adhesive factor in Klebsiella pneumoniae strains responsible for human nosocomial infections. Infect Immun 1992; 60:44–55
    [Google Scholar]
  10. Lesage D. D., Gerbaud G. R., Chabbert Y. A. Carte genetique et structure chez Escherichia coli K12 d’un plasmid de resistance isole de Salmonella ordonez . Ann Microbiol 1975; 126A:435–438
    [Google Scholar]
  11. Bouanchaud D. H., Scavizzi M. R., Chabbert Y. A. Elimination by ethidium bromide of antibiotic resistance in enterobacteria and staphylococci. J Gen Microbiol 1968; 54:417–425
    [Google Scholar]
  12. Sahm D. F., Washington J. A. Antibacterial susceptibility tests: dilution methods. In Balows A., Hausler W. J., Herrmann K. L., Isenberg H. D., Shadomy H. J. (eds) Manual of clinical microbiology 5th edn Washington DC: American Society for Microbiology; 19911105–1116
    [Google Scholar]
  13. Hirakata Y., Furuya N., Tateda K., Kaku M., Yamaguchi K. In vivo production of exotoxin A and its role in endogenous Pseudomonas aeruginosa septicemia in mice. Infect Immun 1993; 61:2468–2473
    [Google Scholar]
  14. Furuya N., Hirakata Y., Tomono K. Mortality rates amongst mice with endogenous septicaemia caused by Pseudomonas aeruginosa isolates from various clinical sources. J Med Microbiol 1993; 39:141–146
    [Google Scholar]
  15. Matsumoto T., Kaku M., Furuya N. Amphotericin B-induced resistance to Pseudomonas aeruginosa infection in mice. J Antibiot Tokyo 1993; 46:777–784
    [Google Scholar]
  16. Hirakata Y., Kaku M., Furuya N. Effect of clearance of bacteria from the blood on the development of systemic bacteraemia in mice. J Med Microbiol 1993; 38:337–344
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/00222615-44-3-211
Loading
/content/journal/jmm/10.1099/00222615-44-3-211
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error